Key Financial Figures (FY 2025-26)

  • Revenue from Operations: ₹1159.47 lakhs (Previous year: ₹304.75 lakhs)
  • Other Income: ₹37.68 lakhs (Previous year: ₹92.13 lakhs)
  • Total Revenue: ₹1197.15 lakhs (Previous year: ₹396.88 lakhs)
  • Profit Before Tax: ₹37.58 lakhs (Previous year: ₹65.02 lakhs)
  • Provision for Tax: ₹8.17 lakhs (Previous year: ₹13.56 lakhs)
  • Deferred Tax Assets: ₹2.17 lakhs
  • Net Profit After Tax: ₹31.57 lakhs (Previous year: ₹51.47 lakhs)
  • Earnings Per Share (Basic & Diluted): ₹0.01 (Previous year: ₹0.02)
  • Transfer to General Reserve: ₹31.57
  • No dividend recommended for the year

Business Performance Highlights

  • Significant revenue growth from ₹396.88 lakhs to ₹1197.15 lakhs year-over-year
  • Net profit decreased from ₹51.47 lakhs to ₹31.57 lakhs
  • FPI investment of 12,379,500 shares representing 5.13% of total equity
  • Company establishing manufacturing plants for tablets, capsules, anesthetic liquid, and sachets with expected commercial production in January 2026

Capital Structure Changes

  • Preferential issue of 5,800,000 equity shares at ₹6 per share (face value ₹1) on March 23, 2026
  • Funds raised: ₹348 lakhs for laboratory equipment, AHU, furniture, and general corporate purposes
  • Listing date for preferential shares: May 07, 2026
  • Authorized share capital increased to ₹26,00,00,000
  • Paid-up share capital as of March 31, 2026: ₹24,13,57,000 (241,357,000 equity shares of ₹1 each)

Migration to Main Board

  • Successfully migrated from BSE SME platform to BSE Main Board effective January 02, 2026
  • Approval received vide Ref. No.: LO/Migration/SN/MIG-TP/634/2025-26
  • Migration approved based on meeting eligibility criteria: paid-up capital > ₹10 crores, market capitalization > ₹25 crores, and 3+ years listed on SME

Registered Office Change

  • Changed effective January 21, 2026 from:

Previous: 610, Colonade, Behind Iscon Temple, Opposite Iscon BRTS Bus Stand, Iscon-Ambli Road, Ahmedabad-380058

New: 504, 5th Floor Iscon Elegence, Circle-P, Sarkhej Gandhinagar Highway, S A C, Ahmedabad-380015

Amalgamation Plan

  • Board approved scheme of amalgamation with Zenith Healthcare Limited on July 14, 2026
  • Achyut Healthcare Limited (Transferor Company) to amalgamate with Zenith Healthcare Limited (Transferee Company)
  • Share exchange ratio: 119 equity shares of Zenith for every 50 equity shares of Achyut
  • Consideration: No cash consideration, only equity shares
  • Subject to approvals from NCLT, shareholders, creditors, and regulatory authorities
  • Rationale: Business synergy, expanded product portfolio, manufacturing capacity optimization, and simplified group structure

AGM Details

  • Date: September 29, 2026 (Tuesday)
  • Time: 10:30 AM onwards
  • Mode: Video Conferencing/Other Audio Visual Mode
  • Record Date: September 22, 2026
  • Remote e-voting period: September 26, 2026 (9:00 AM) to September 28, 2026 (5:00 PM)

Agenda Items

Ordinary Business

1. Adoption of audited financial statements for FY 2025-26

2. Reappointment of Mr. Mahendra C. Raycha (DIN: 00577647) who retires by rotation

Special Business

3. Reappointment of Mr. Jigen J. Modi (DIN: 03355555) as Managing Director for 5 years from November 01, 2026 to October 31, 2031 with remuneration of ₹1,80,000 per annum

4. Reappointment of Mrs. Sonu Lalitkumar Jain (DIN: 09387661) as Non-Executive Independent Director for 5 years from November 01, 2026 to October 31, 2031 with sitting fees of ₹36,000

5. Reappointment of Mr. Rutvik Sanjaykumar Thakkar (DIN: 09387486) as Non-Executive Independent Director for 5 years from November 01, 2026 to October 31, 2031 with sitting fees of ₹36,000

Board Composition

  • Mr. Jigen J. Modi - Managing Director/CFO
  • Mr. Mahendra C. Raycha - Chairman & Non-Executive Director
  • Mrs. Amisha J. Modi - Executive Director
  • Mr. Akshit M. Raycha - Non-Executive Director
  • Mr. Rutvik S. Thakkar - Independent Director
  • Ms. Sonu L. Jain - Independent Director
  • Mr. Paragkumar S Dave - Independent Director
  • Mr. Rajesh C Sutaria - Independent Director

Key Managerial Personnel

  • Mr. Kaushalkumar Shrikrishnabhai Dave - Company Secretary (appointed w.e.f. June 05, 2025)
  • Mr. Jigen J. Modi - CFO

Corporate Governance

  • Board met 8 times during the year
  • Audit Committee met 4 times
  • Nomination and Remuneration Committee met 2 times
  • Stakeholders Relationship Committee met 2 times
  • Whistle Blower Policy implemented and operational

Manufacturing Facility Update

  • Developing pharmaceutical manufacturing facility at Survey No. 1078, Bhat Chacharvadi Road, Taluka Daskori, Bhat Village, Dist. Ahmedabad
  • Intended to conform to EU Good Manufacturing Practice (GMP) certification standards
  • Expected to start commercial production in January 2026

Foreign Exchange Details

  • Foreign Exchange Earned: ₹477.58 lakhs (from sale of finished goods)
  • Foreign Exchange Outgo: Nil

Voting Instructions

  • Remote e-voting through NSDL platform
  • Shareholders can vote from September 26, 2026 (9:00 AM) to September 28, 2026 (5:00 PM)
  • Physical attendance dispensed with due to MCA circulars allowing VC/OAVM meetings

Inspection of Documents

  • Relevant documents available for inspection at registered office during business hours
  • Annual report available on company website: www.achyuthealthcare.com

#Tags: #AchyutHealthcare #AnnualReport #SEBIRegulation34 #AGM2026 #Pharmaceuticals #Amalgamation #BSEListing #FinancialResults #Neutral